PL376659A1 - Skondensowane związki heterocykliczne - Google Patents

Skondensowane związki heterocykliczne

Info

Publication number
PL376659A1
PL376659A1 PL376659A PL37665903A PL376659A1 PL 376659 A1 PL376659 A1 PL 376659A1 PL 376659 A PL376659 A PL 376659A PL 37665903 A PL37665903 A PL 37665903A PL 376659 A1 PL376659 A1 PL 376659A1
Authority
PL
Poland
Prior art keywords
heterocyclic compounds
fused heterocyclic
fused
compounds
heterocyclic
Prior art date
Application number
PL376659A
Other languages
English (en)
Inventor
Xi Chen
Xiaoqi Chen
Pingchen Fan
Juan Jaen
Leping Li
Jeffrey T. Mihalic
Original Assignee
Tularik Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc. filed Critical Tularik Inc.
Publication of PL376659A1 publication Critical patent/PL376659A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL376659A 2002-11-06 2003-11-06 Skondensowane związki heterocykliczne PL376659A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42445602P 2002-11-06 2002-11-06

Publications (1)

Publication Number Publication Date
PL376659A1 true PL376659A1 (pl) 2006-01-09

Family

ID=32312811

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376659A PL376659A1 (pl) 2002-11-06 2003-11-06 Skondensowane związki heterocykliczne

Country Status (16)

Country Link
US (2) US7253179B2 (pl)
EP (1) EP1562943A1 (pl)
JP (1) JP4547266B2 (pl)
KR (1) KR20050103184A (pl)
CN (2) CN101134757A (pl)
AU (1) AU2003285160B2 (pl)
BR (1) BR0316070A (pl)
CA (1) CA2505372A1 (pl)
EA (1) EA009421B1 (pl)
IS (1) IS7833A (pl)
MX (1) MXPA05004739A (pl)
NO (1) NO20052655L (pl)
NZ (1) NZ540328A (pl)
PL (1) PL376659A1 (pl)
WO (1) WO2004043958A1 (pl)
ZA (1) ZA200503654B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
CN101134757A (zh) 2002-11-06 2008-03-05 安姆根有限公司 稠合杂环化合物
EP1595867A4 (en) 2003-02-10 2008-05-21 Banyu Pharma Co Ltd PIPERIDINE DERIVATIVES AS AN ACTIVE ANTAGONIST AT THE RECIPE OF MELANIN CONCENTRATING HORMONE
DE102010025663A1 (de) * 2010-06-30 2012-01-05 Karl-Heinz Glüsenkamp Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate
MX2013001612A (es) * 2010-08-10 2013-07-05 Abbvie Inc Moduladores de trpv3 novedosos.
US9012651B2 (en) 2011-03-24 2015-04-21 Abbvie Inc. TRPV3 modulators
WO2013062964A2 (en) 2011-10-24 2013-05-02 Abbvie Inc. Novel trpv3 modulators
CN106588812B (zh) * 2016-12-07 2019-02-22 烟台大学 一种酰氯制备2，4-二取代噻唑啉类化合物的方法
CN120208846A (zh) * 2019-01-14 2025-06-27 载度思生命科学有限公司 经取代的磺酰脲类衍生物
HUP2200222A1 (hu) 2022-06-17 2023-12-28 Richter Gedeon Nyrt MCHR1 antagonisták a Prader-Willi szindróma kezelésére

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US176694A (en) * 1876-04-25 Improvement in screw-cutting die-stocks
US23085A (en) * 1859-03-01 chandler
US199549A (en) * 1878-01-22 Improvement in screw-propellers
JPS5825980B2 (ja) 1976-02-12 1983-05-31 ヤマサ醤油株式会社 サイクリックヌクレオチドの定量法
EP0257701A1 (en) 1986-08-15 1988-03-02 Cedona Pharmaceuticals B.V. A process for preparing hydroxyl derivatives of compounds containing a carbazole, dibenzofurane or dibenzothiophene group
US5049655A (en) 1989-03-22 1991-09-17 The Salk Institute For Biological Studies Melanin-concentrating hormones
JP2906654B2 (ja) 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
JP3160941B2 (ja) 1991-06-17 2001-04-25 東レ株式会社 カルバゾール誘導体および免疫抑制剤
CA2112744A1 (en) 1991-07-05 1993-01-21 Vittorrio Vecchietti Hydroisoquinoline derivatives
KR100301093B1 (ko) 1992-09-29 2001-10-22 히라이 가쯔히꼬 인돌유도체,그제조방법및그의약용도
US5272146A (en) 1992-10-02 1993-12-21 The United States Of America As Represented By The United States Department Of Health And Human Services 1,2-dihydroellipticines with activity against CNS specific cancer cell lines
US5457208A (en) 1993-06-21 1995-10-10 Regents Of The University Of Minnesota Kappa opioid receptor antagonists
US5464841A (en) 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
US5578725A (en) 1995-01-30 1996-11-26 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5849708A (en) 1995-06-06 1998-12-15 Joslin Diabetes Center, Inc. Promotion of eating behavior
EP0848060A3 (en) 1996-12-11 2000-02-02 Smithkline Beecham Corporation Novel human 11CB splice variant
AU739367B2 (en) 1997-01-16 2001-10-11 Toray Industries, Inc. Indolomorphinan derivative and agent for curing and preventing cerebral disorder
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP1042498A4 (en) 1997-12-03 2003-05-07 Smithkline Beecham Corp METHOD FOR SEARCHING FOR AN AGONIST OR ANTAGONIST OF THE HUMAN 11 CB SPLICE VARIANT
WO1999064002A1 (en) 1998-06-11 1999-12-16 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
EP1114155A2 (en) 1998-09-17 2001-07-11 Incyte Pharmaceuticals, Inc. Human gpcr proteins
GB9822158D0 (en) 1998-10-09 1998-12-02 Nycomed Imaging As Compositions
AU1802000A (en) 1998-12-28 2000-07-24 Takeda Chemical Industries Ltd. Screening method
US6221613B1 (en) 1998-12-31 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
WO2000049170A1 (en) 1999-02-18 2000-08-24 Smithkline Beecham Corporation MURINE 11cby RECEPTOR
EP1153932A1 (en) 1999-02-19 2001-11-14 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
WO2000070347A1 (en) 1999-05-19 2000-11-23 Astrazeneca Ab Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1)
WO2000075166A1 (en) 1999-06-08 2000-12-14 The Regents Of The University Of California Melanin concentrating hormone receptor
CA2378917A1 (en) 1999-07-14 2001-01-25 Merck & Co., Inc. Melanin-concentrating hormone receptor
JP2003505082A (ja) 1999-07-26 2003-02-12 ジェネンテック・インコーポレーテッド 新規なポリヌクレオチドとその使用法
WO2001007606A1 (en) 1999-07-27 2001-02-01 Smithkline Beecham Plc Axor21, a g-protein coupled receptor
WO2001021169A1 (en) 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Mch antagonists
EP1218336A2 (en) 1999-09-20 2002-07-03 Takeda Chemical Industries, Ltd. Melanin concentrating hormone antagonist
WO2001036479A1 (en) 1999-11-16 2001-05-25 Merck & Co., Inc. G-protein coupled receptor
JP2001226269A (ja) 2000-02-18 2001-08-21 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
JP2003532388A (ja) 2000-03-15 2003-11-05 メルク エンド カムパニー インコーポレーテッド メラニン凝集ホルモン受容体キメラおよび融合タンパク質
JP2005229804A (ja) 2000-03-24 2005-09-02 Astellas Pharma Inc 新規なメラニンコンセントレーティングホルモン受容体
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist
WO2002002744A2 (en) 2000-07-05 2002-01-10 Synaptic Pharmaceutical Corporation Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
EP1299362A4 (en) 2000-07-05 2004-11-03 Synaptic Pharma Corp SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
DE60143525D1 (de) 2000-07-05 2011-01-05 Takeda Pharmaceutical Verfahren zum screenen von mhc-rezeptorantagonisten oder -agonisten
JP2004516239A (ja) * 2000-07-06 2004-06-03 ニューロジェン コーポレイション メラニン凝集ホルモン受容体リガンド
CN1469876A (zh) 2000-10-20 2004-01-21 �Ʒ� α-芳基乙醇胺及其用作β-3肾上腺素能受体激动剂的用途
US20030022891A1 (en) 2000-12-01 2003-01-30 Anandan Palani MCH antagonists and their use in the treatment of obesity
JP4025200B2 (ja) * 2000-12-22 2007-12-19 シェーリング コーポレイション ピペリジンｍｃｈアンタゴニストおよび肥満の処置におけるそれらの使用
US6900329B2 (en) 2001-03-21 2005-05-31 Schering Corporation MCH antagonists and their use in the treatment of obesity
IL157456A0 (en) 2001-03-21 2004-03-28 Pharmacopeia Inc Pharmacopeia Aryl and biaryl compounds having mch modulatory activity
ATE460163T1 (de) * 2001-04-12 2010-03-15 Pharmacopeia Llc Arly und diaryl piperidinderivate verwendbar als mch-hemmer
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US6858619B2 (en) 2001-05-04 2005-02-22 Amgen Inc. Fused heterocyclic compounds
CA2448080A1 (en) 2001-05-22 2002-11-28 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
KR20040058307A (ko) * 2001-11-26 2004-07-03 쉐링 코포레이션 비만 및 ｃｎｓ 장애를 치료하기 위한 피페리딘계 ｍｃｈ길항제
US7160879B2 (en) 2002-01-10 2007-01-09 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
CN101134757A (zh) * 2002-11-06 2008-03-05 安姆根有限公司 稠合杂环化合物

Also Published As

Publication number Publication date
EA009421B1 (ru) 2007-12-28
EA200500770A1 (ru) 2005-12-29
CN1735613A (zh) 2006-02-15
KR20050103184A (ko) 2005-10-27
US20040147538A1 (en) 2004-07-29
NO20052655D0 (no) 2005-06-02
JP2006508130A (ja) 2006-03-09
NO20052655L (no) 2005-07-26
AU2003285160B2 (en) 2009-06-04
MXPA05004739A (es) 2005-08-02
NZ540328A (en) 2008-02-29
BR0316070A (pt) 2005-09-27
CA2505372A1 (en) 2004-05-27
AU2003285160A1 (en) 2004-06-03
IS7833A (is) 2005-05-02
WO2004043958A1 (en) 2004-05-27
US7253179B2 (en) 2007-08-07
ZA200503654B (en) 2006-09-27
JP4547266B2 (ja) 2010-09-22
EP1562943A1 (en) 2005-08-17
US20080058365A1 (en) 2008-03-06
CN1330651C (zh) 2007-08-08
CN101134757A (zh) 2008-03-05

Similar Documents

Publication Publication Date Title
EP1687002A4 (en) CONDENSED HETEROCYCLIC COMPOUNDS
IL174283A0 (en) Fused heterocyclic compounds
PL377087A1 (pl) Związki heterocykliczne
PT2042504E (pt) Derivados da azolepirimidina fundida
AU2003291310A8 (en) Fused heterocyclic compounds and use thereof
PL374544A1 (pl) Związki imidazo-skondensowane
ZA200603881B (en) Substituted fused heterocyclic C-glycosides
IL175489A0 (en) Substituted fused heterocyclic c-glycosides
IL165178A0 (en) Novel fused imidazole derivative
IL179414A0 (en) Fused heterocyclic compound
TWI341314B (en) New compounds
IL177933A0 (en) New compounds
IL166650A0 (en) New compounds
AU2003264018A8 (en) New compounds
IL163894A0 (en) New compounds
GB0315870D0 (en) Heterocyclic derivatives
PL378249A1 (pl) Skondensowane pochodne furanu
MY143373A (en) Novel fused pyrrolocarbazoles
EP1737446A4 (en) CONDENSED HETEROCYCLIC COMPOUNDS
EP1476425A4 (en) Heterocyclic Aryl Sulphonamidocyclic Compounds
GB0120818D0 (en) Heterocyclic compounds
HU0203976D0 (en) New compounds
PL376659A1 (pl) Skondensowane związki heterocykliczne
AU2003280578A1 (en) Heterocyclic compounds
GB0226609D0 (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)